Search results
Ranveer Singh reviews Kalki 2898 AD, lauds wife Deepika Padukone's stellar performance
Indiatimes· 20 hours agoOn Tuesday night, Deepika Padukone and Ranveer Singh, who are expecting their first child together,...
Kalki 2898 AD: Vijay Deverakonda's Fees REVEALED, Here's How Much He Charged for Arjuna Cameo -...
News18· 3 days agoIt is no longer a secret that Vijay Deverakonda is a part of Kalki 2898 AD. The Telugu superstar had...
Kalki 2898 AD: Vijay Deverakonda Feels 'Overwhelmed', Hopes Prabhas Starrer Mints 'Rs 1000 Cr And...
News18· 5 days agoVijay Deverakonda has finally watched Kalki 2898 AD and he is impressed, to say the least. Vijay has...
Rashmika Mandanna And Vijay Deverakonda Join The Kalki 2898 AD Fan Club: "Hope It Makes A 1000...
NDTV· 4 days agoKalki 2898 AD is ruling the box office and how. Not only the fans, but celebrities are also equally impressed by Nag Ashwin's magnum opus. On Saturday, Vijay Deverakonda, who plays a cameo in ...
Tv series 2024 | best tv series of all time - Pinkvilla
Pinkvilla· 17 hours agoIn fact, the concept of TV series has offered a whole new perspective and worked as the perfect push to break out of the conventional 3-hour film concept., It has clearly ...
Rajnikanth, Allu Arjun, Yash praise Prabhas-Amitabh Bachchan’s Kalki 2898 AD: ‘Nag Ashwin has taken...
Indian Express· 4 days agoSeveral stars from the South have praised Prabhas, Deepika Padukone, and Amitabh Bachchan starrer...
Kalki 2898 AD: Vijay Deverakonda and Rashmika Mandanna heaps praise for Prabhas and Deepika Padukone...
Mid Day· 5 days agoKalki 2898 AD: Rashmika Mandanna and Vijay Devarakonda have shared their opinion about Nag Ashwini’s...
IIM Sambalpur commences 10th MBA batch with 76% women enrollment
Hindustan Times· 1 day agoThe institute informed that 19 per cent of the non-engineers have science and commerce backgrounds,...
The Simply Good Foods Co. to acquire protein peer Only What You Need
Just Food· 5 days ago"We'll also look to leverage the knowledge of our collective R&D teams to continue to enhance core...
5 FDA decisions to watch in the third quarter
BioPharma Dive· 14 hours agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...